HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CymaBay Therapeutics (CBAY) Investors Who Have Suffered Losses to Contact its Attorneys: Firm Investigating Possible Securities Fraud

SAN FRANCISCO, Feb. 28, 2020 /PRNewswire/ -- Hagens Berman urges investors in CymaBay Therapeutics, Inc. (NASDAQ: CBAY) who have suffered significant losses to submit their losses now. The firm is investigating possible securities law violations, and certain investors may have valuable...

from PR Newswire: https://ift.tt/2vi990K